This Week in Nature

A news article in Nature looks into the problems inherited by the new FDA commissioner Margaret Hamburg: "The FDA, once globally revered as the gold standard in regulation of food and medical-product safety, has lapsed repeatedly in recent years under a string of different leaders and a long stretch without any permanent chief," the article says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.